CD274 and neoplasm: Notably, the combination of TMB or TNB with M1-macrophage signature evaluation statistically elevated the prognostic and predictive value of anti-PD-L1 efficacy, when compared with TMB, TNB, or M1 macrophages, indicating that there are some potential mechanisms beyond T cell anti-tumor immune processes mediated by mutations and tumor neoantigens.